Skip to content
Catalyst

PapersPMID:14725614

Effects of gamma-butyrobetaine and mildronate on nitric oxide production in lipopolysaccharide-treated rats.

Basic & clinical pharmacology & toxicology2004The record ↗

  1. Finding, insufficient evidencelowersnitric oxide

What moved

1 findingHow to read these marks →
  • “Its natural analogue gamma-butyrobetaine (30 mg/kg) triggered a twofold decrease of the nitric oxide concentration in all studied tissues 30 min. after the administration.”
    Study
    animal · not in humans
    Dose studied
    gamma-butyrobetaine 30 mg/kg, single dose
    Population
    rats treated with lipopolysaccharide (10 mg/kg, 4 h); nitric oxide measured by electron paramagnetic resonance in liver, heart, blood, kidney, brain cortex, cerebellum and testes; single timepoint 30 min after dosing

Study record

Design
animal study, in vivo
Species
animal / mixed
Population
lipopolysaccharide-treated rats
Participants
not reported
Comparator
no treatment / not stated in the paper
Duration
not reported
Endpoints measured
12